Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Broccoli sprouts are used to support cardiovascular health primarily due to their high content of sulforaphane, a bioactive compound that has been investigated for its antioxidant and anti-inflammatory properties. Several preclinical and limited clinical studies suggest that sulforaphane may improve endothelial function, reduce oxidative stress, and lower markers of inflammation, all of which are relevant to cardiovascular disease (CVD) risk. Animal studies have demonstrated that broccoli sprout extracts can reduce atherosclerotic plaque formation and improve vascular function. Small human studies have shown potential benefits, such as reduction in LDL oxidation and improvement in blood pressure, though these studies are often limited by small sample sizes and short durations.

While there is scientific interest and some supportive data, the evidence is not yet robust or conclusive. Most clinical trials are preliminary, with mixed results regarding actual CVD outcomes. Major cardiovascular guidelines do not currently recommend broccoli sprouts or sulforaphane supplements as standard therapy for CVD prevention or treatment. However, the potential mechanisms—particularly antioxidant and anti-inflammatory effects—are biologically plausible and continue to be explored in ongoing research.

In summary, there is a growing body of scientific evidence suggesting that broccoli sprouts may offer cardiovascular benefits, but large-scale, long-term human trials are needed before definitive conclusions can be drawn or routine clinical use recommended.

More about Broccoli sprout
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Broccoli sprout

Products containing Broccoli sprout